Robert Baffi, EVP, Technical Operations at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 60,000 shares at $46.00 ($2.8M) on 2012-11-05, disclosed to the SEC on 2012-11-07.
Scheduled sale ($2.8M) by EVP, Technical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.00 | 20,000 | $920K | 32.4% |
| 2 | $47.00 | 5,770 | $271K | 9.5% |
| 3 | $47.00 | 14,230 | $669K | 23.5% |
| 4 | $49.00 | 20,000 | $980K | 34.5% |
| Total | $47.33 avg | 60,000 | $2.8M | 100% |
| Filing → |
| BMRN | SELL | 2017-10-02 | $2.0M | — | Filing → |
| BMRN | SELL | 2016-05-19 | $435K | — | Filing → |
| BMRN | SELL | 2015-03-05 | $1.6M | — | Filing → |